Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Ph phase_1

25%

Ph phase_4

25%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Other(1)

Detailed Status

Recruiting2

Completed1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (25.0%)

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A1 (25.0%)

Trials by Status

completed125%

unknown125%

recruiting250%

Recent Activity

2 active trials

Showing 4 of 4

recruitingnot_applicable

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

NCT05057702

recruitingphase_4

Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial

NCT06299670

completedphase_2

Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

NCT05414461

unknownphase_1

HDDO-1801 Intervention Trial

NCT04097951

Clinical Trials (4)

Showing 4 of 4 trials

NCT05057702Not Applicable

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Recruiting

NCT06299670Phase 4

Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial

Recruiting

NCT05414461Phase 2

Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

Completed

NCT04097951Phase 1

HDDO-1801 Intervention Trial

Unknown

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4